sulbactam has been researched along with Coagulation Disorders, Blood in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, K; Lu, J; Ren, Y; Shao, X; Sun, H; Tian, X; Wei, J; Xie, N | 1 |
| Dong, D; Li, J; Li, S; Liu, Y; Su, N; Sun, X; Tan, J; Wang, W; Wu, G; Wu, Y; Xiong, W; Yu, C; Zhang, R; Zong, Z; Zou, K | 1 |
2 other study(ies) available for sulbactam and Coagulation Disorders, Blood
| Article | Year |
|---|---|
Effect of Cefoperazone/Sulbactam on Blood Coagulation Function in Infected Emergency Department Patients and the Necessity of Vitamin K1 (VK1) Preventive Intervention: A Single-Center, Retrospective Analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Blood Coagulation; Blood Coagulation Disorders; Cefoperazone; Emergency Service, Hospital; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Sulbactam; Vitamin K 1 | 2023 |
Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Blood Coagulation Disorders; Blood Platelets; Cefoperazone; Ceftazidime; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Prothrombin Time; Sulbactam; Tazobactam; Young Adult | 2020 |